{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:31:05Z","timestamp":1782977465774,"version":"3.54.5"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T00:00:00Z","timestamp":1644019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T00:00:00Z","timestamp":1644019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The Dementia Management Act (DMA) came into effect on August 4, 2011, in South Korea. Diagnosis and medication were rapidly performed for dementia in a short time. We investigated the cardiac effects of increased drug prescription following DMA. We observed a correlation between Alzheimer\u2019s disease (AD) and anti-AD drug (AAD) groups from 2010 to 2019 on the National Health Insurance System (NHIS) of South Korea. This study investigated the increase and decrease in deaths of AD patients with AAD. We analysed the mortality per 100,000 population with the\n                    <jats:italic>R<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    Calculator. Moreover, we made the up or down datum line for the simple decision on the listed, delisted, and sustainable drug examined by a linear equation and\n                    <jats:italic>R<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    . We observed that life expectancy was diminished by AAD in Sorokdo National Hospital. In the NHIS, donepezil and rivastigmine increased the number of deaths decided on\n                    <jats:italic>R<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    \u2009&gt;\u20090.75. Memantine was sustainable. We could not decide on galantamine because it is one of the other groups. We made a straightforward decision-maker of delisted, listed, or sustainable criteria based on mortality and datum line.\n                  <\/jats:p>","DOI":"10.1007\/s00210-022-02209-3","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T23:28:33Z","timestamp":1644017313000},"page":"535-546","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The listed, delisted, and sustainability of therapeutic medicines for dementia patients: the study is specific to South Korea"],"prefix":"10.1007","volume":"395","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1775-5656","authenticated-orcid":false,"given":"Jong Hoon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,5]]},"reference":[{"issue":"6","key":"2209_CR1","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s12272-014-0500-8","volume":"38","author":"SH Ahn","year":"2015","unstructured":"Ahn SH, Choi NK, Kim YJ, Seong JM, Shin JY, Jung SY et al (2015) Drug persistency of cholinesterase inhibitors for patients with dementia of Alzheimer type in Korea. Arch Pharm Res 38(6):1255\u20131262","journal-title":"Arch Pharm Res"},{"issue":"3","key":"2209_CR2","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1124\/jpet.105.090365","volume":"315","author":"E Arias","year":"2005","unstructured":"Arias E, Gallego-Sand\u00edn S, Villarroya M, Garc\u00eda AG, L\u00f3pez MG (2005) Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. J Pharmacol Exp Ther 315(3):1346\u20131353","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2209_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.trci.2019.05.005","volume":"5","author":"S Bhattacharjee","year":"2019","unstructured":"Bhattacharjee S, Patanwala AE, Lo-Ciganic WH, Malone DC, Lee JK, Knapp SM et al (2019) Alzheimer\u2019s disease medication and risk of all-cause mortality and all-cause hospitalization: a retrospective cohort study. Alzheimers Dement (n y) 5(1):294\u2013302","journal-title":"Alzheimers Dement (n y)"},{"issue":"Suppl 1","key":"2209_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000138503","volume":"37","author":"NJ Birdsall","year":"1988","unstructured":"Birdsall NJ, Curtis CA, Eveleigh P, Hulme EC, Pedder EK, Poyner D et al (1988) Muscarinic receptor subtypes and the selectivity of agonists and antagonists. Pharmacology 37(Suppl 1):22\u201331","journal-title":"Pharmacology"},{"issue":"2","key":"2209_CR5","doi-asserted-by":"publisher","first-page":"220","DOI":"10.47276\/lr.91.2.220","volume":"91","author":"CR Butlin","year":"2020","unstructured":"Butlin CR (2020) Excess of deaths of leprosy-affected people. Lepr Rev 91(2):220\u2013223","journal-title":"Lepr Rev"},{"issue":"45","key":"2209_CR6","doi-asserted-by":"publisher","first-page":"19326","DOI":"10.1073\/pnas.1005078107","volume":"107","author":"SC Cho","year":"2010","unstructured":"Cho SC, Park MC, Keam B, Choi JM, Cho Y, Hyun S et al (2010) DDS, 4,4\u2032-diaminodiphenylsulfone, extends organismic lifespan. Proc Natl Acad Sci U S A 107(45):19326\u201319331","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2209_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3858\/emm.2011.43.9.060","volume":"43","author":"SC Cho","year":"2011","unstructured":"Cho SC, Rhim JH, Choi HR, Son YH, Lee SJ, Song KY et al (2011) Protective effect of 4,4\u2032-diaminodiphenylsulfone against paraquat-induced mouse lung injury. Exp Mol Med 43(9):525\u2013537","journal-title":"Exp Mol Med"},{"issue":"3","key":"2209_CR8","first-page":"1","volume":"2014","author":"Y Cho","year":"2014","unstructured":"Cho Y, Shim E, Lee KS, Park SC (2014) Mortality profiles of leprosy-affected elderly in Korea: a demographic perspective. Asia-Pac E-J Health Soc Sci 2014(3):1\u20135","journal-title":"Asia-Pac E-J Health Soc Sci"},{"key":"2209_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.tma.2019.07.001","volume":"3","author":"H Choi","year":"2019","unstructured":"Choi H, Cho SC, Ha YW, Ocampo B, Park S, Chen S et al (2019) DDS promotes longevity through a microbiome-mediated starvation signal. Transl Med Aging 3:64\u201369","journal-title":"Transl Med Aging"},{"key":"2209_CR10","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/spol.12092","volume":"48","author":"Y Chon","year":"2014","unstructured":"Chon Y (2014) The expansion of the Korean welfare state and its results@ focusing on lon\u2021 term care insurance for the elderly. Soc Policy Adm 48:704\u2013720","journal-title":"Soc Policy Adm"},{"issue":"9427","key":"2209_CR11","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/S0140-6736(04)16499-4","volume":"363","author":"C Courtney","year":"2004","unstructured":"Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E et al (2004) Long-term donepezil treatment in 565 patients with Alzheimer\u2019s disease (AD2000): randomised double-blind trial. Lancet (london, England) 363(9427):2105\u20132115","journal-title":"Lancet (london, England)"},{"key":"2209_CR12","unstructured":"Dementia Management Act, Act No.15649 (2018)."},{"issue":"1","key":"2209_CR13","doi-asserted-by":"publisher","first-page":"e0210695","DOI":"10.1371\/journal.pone.0210695","volume":"14","author":"Y Du","year":"2019","unstructured":"Du Y, Wolf IK, Busch MA, Knopf H (2019) Associations between the use of specific psychotropic drugs and all-cause mortality among older adults in Germany: results of the mortality follow-up of the German National Health Interview and Examination Survey 1998. PLoS One. 14(1):e0210695","journal-title":"PLoS One."},{"issue":"1","key":"2209_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/jama.2013.282834","volume":"311","author":"MW Dysken","year":"2014","unstructured":"Dysken MW, Sano M, Asthana S, Vertrees JE, Pallaki M, Llorente M et al (2014) Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA 311(1):33\u201344","journal-title":"JAMA"},{"issue":"2","key":"2209_CR15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12012-019-09543-8","volume":"20","author":"C Ellermann","year":"2020","unstructured":"Ellermann C, Coenen A, Niehues P, Leitz P, Kochh\u00e4user S, Dechering DG et al (2020) Proarrhythmic effect of acetylcholine-esterase inhibitors used in the treatment of Alzheimer\u2019s disease: benefit of rivastigmine in an experimental whole-heart model. Cardiovasc Toxicol 20(2):168\u2013175","journal-title":"Cardiovasc Toxicol"},{"issue":"5","key":"2209_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.amjmed.2006.08.036","volume":"120","author":"MR Farlow","year":"2007","unstructured":"Farlow MR, Cummings JL (2007) Effective pharmacologic management of Alzheimer\u2019s disease. Am J Med 120(5):388\u2013397","journal-title":"Am J Med"},{"issue":"6","key":"2209_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S1474-4422(07)70109-6","volume":"6","author":"HH Feldman","year":"2007","unstructured":"Feldman HH, Ferris S, Winblad B, Sfikas N, Mancione L, He Y et al (2007) Effect of rivastigmine on delay to diagnosis of Alzheimer\u2019s disease from mild cognitive impairment: the InDDEx study. Lancet Neurol 6(6):501\u2013512","journal-title":"Lancet Neurol"},{"issue":"1","key":"2209_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/jir.12314","volume":"61","author":"G Glover","year":"2017","unstructured":"Glover G, Williams R, Heslop P, Oyinlola J, Grey J (2017) Mortality in people with intellectual disabilities in England. J Intellect Disabil Res 61(1):62\u201374","journal-title":"J Intellect Disabil Res"},{"issue":"1","key":"2209_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1001\/archneur.57.1.94","volume":"57","author":"SM Greenberg","year":"2000","unstructured":"Greenberg SM, Tennis MK, Brown LB, Gomez-Isla T, Hayden DL, Schoenfeld DA et al (2000) Donepezil therapy in clinical practice: a randomized crossover study. Arch Neurol 57(1):94\u201399","journal-title":"Arch Neurol"},{"issue":"3","key":"2209_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/ntr\/nty116","volume":"21","author":"JL Hoskin","year":"2018","unstructured":"Hoskin JL, Al-Hasan Y, Sabbagh MN (2018) Nicotinic acetylcholine receptor agonists for the treatment of Alzheimer\u2019s dementia: an update. Nicotine Tob Res 21(3):370\u2013376","journal-title":"Nicotine Tob Res"},{"issue":"2 Pt 1","key":"2209_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1067\/mjd.2000.105567","volume":"43","author":"W Huang","year":"2000","unstructured":"Huang W, Foster JA, Rogachefsky AS (2000) Pharmacology of botulinum toxin. J Am Acad Dermatol 43(2 Pt 1):249\u2013259","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"2209_CR22","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1212\/01.wnl.0000244430.39969.5f","volume":"67","author":"A Hunderfund","year":"2006","unstructured":"Hunderfund A, Roberts RO, Slusser T, Leibson C, Geda YE, Ivnik R et al (2006) Mortality in amnestic mild cognitive impairment: a prospective community study. Neurology 67(10):1764\u20131768","journal-title":"Neurology"},{"key":"2209_CR23","first-page":"178","volume":"264","author":"EJ Hwang","year":"2019","unstructured":"Hwang EJ, Park HA, Sohn SK, Lee HB, Choi HK, Ha S et al (2019) Mapping Korean EDI medical procedure code to SNOMED CT. Stud Health Technol Inform 264:178\u2013182","journal-title":"Stud Health Technol Inform"},{"issue":"4","key":"2209_CR24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/WAD.0000000000000401","volume":"34","author":"AT Isik","year":"2020","unstructured":"Isik AT, AtesBulut E, Dokuzlar O, Kaya D, Erken N, DostGunay FS et al (2020) Cardiac and blood pressure safety of transdermal rivastigmine in elderly patients with dementia with lewy bodies. Alzheimer Dis Assoc Disord 34(4):339\u2013343","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"9","key":"2209_CR25","doi-asserted-by":"publisher","first-page":"e0220885","DOI":"10.1371\/journal.pone.0220885","volume":"14","author":"S Jordan","year":"2019","unstructured":"Jordan S, Banner T, Gabe-Walters M, Mikhail JM, Panes G, Round J et al (2019) Nurse-led medicines\u2019 monitoring in care homes, implementing the Adverse Drug Reaction (ADRe) Profile improvement initiative for mental health medicines: an observational and interview study. PLoS One. 14(9):e0220885","journal-title":"PLoS One."},{"issue":"1","key":"2209_CR26","first-page":"24","volume":"16","author":"HS Kang","year":"2012","unstructured":"Kang HS, Yun JH, Ahn IS, Moon YJ, Hwang TY, Lee YM et al (2012) Effects of galantamine treatment on attention, activities of daily living, and neuropsychiatric symptoms between the patients with pure Alzheimer\u2019s disease and mixed dementia. J Korean Geriatr Psychiatry 16(1):24\u201330","journal-title":"J Korean Geriatr Psychiatry"},{"issue":"6","key":"2209_CR27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/1533317518775044","volume":"33","author":"J Kazmierski","year":"2018","unstructured":"Kazmierski J, Messini-Zachou C, Gkioka M, Tsolaki M (2018) The impact of a long-term rivastigmine and donepezil treatment on all-cause mortality in patients with Alzheimer\u2019s disease. American Journal of Alzheimer\u2019s Disease & Other Dementias. 33(6):385\u201393","journal-title":"American Journal of Alzheimer\u2019s Disease & Other Dementias."},{"issue":"2","key":"2209_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000515926","volume":"11","author":"A Khattak","year":"2021","unstructured":"Khattak A, Kanwar B, Sergi C, Lee Chul J, Balentine J, Lee J-H et al (2021) Commentary for the elderly in the pandemic era. Dementia and Geriatric Cognitive Disorders Extra 11(2):168\u2013171","journal-title":"Dementia and Geriatric Cognitive Disorders Extra"},{"issue":"3","key":"2209_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/2042098617750555","volume":"9","author":"R Khoury","year":"2018","unstructured":"Khoury R, Rajamanickam J, Grossberg GT (2018) An update on the safety of current therapies for Alzheimer\u2019s disease: focus on rivastigmine. Therapeutic Advances in Drug Safety 9(3):171\u2013178","journal-title":"Therapeutic Advances in Drug Safety"},{"issue":"2","key":"2209_CR30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3233\/JAD-180843","volume":"66","author":"P Krolak-Salmon","year":"2018","unstructured":"Krolak-Salmon P, Dubois B, Sellal F, Delabrousse-Mayoux JP, Vandel P, Amieva H et al (2018) France will no more reimburse available symptomatic drugs against Alzheimer\u2019s disease. J Alzheimers Dis 66(2):425\u2013427","journal-title":"J Alzheimers Dis"},{"issue":"Pt C","key":"2209_CR31","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.neuropharm.2017.11.018","volume":"136","author":"EP Lebois","year":"2018","unstructured":"Lebois EP, Thorn C, Edgerton JR, Popiolek M, Xi S (2018) Muscarinic receptor subtype distribution in the central nervous system and relevance to aging and Alzheimer\u2019s disease. Neuropharmacology 136(Pt C):362\u2013373","journal-title":"Neuropharmacology"},{"issue":"2","key":"2209_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4235\/agmr.19.0024","volume":"23","author":"SB Lee","year":"2019","unstructured":"Lee SB (2019a) The community dementia reassurance center (chime ansim center) in South Korea. Ann Geriatr Med Res 23(2):43\u201344","journal-title":"Ann Geriatr Med Res"},{"issue":"4","key":"2209_CR33","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/maq.12532","volume":"33","author":"J Lee","year":"2019","unstructured":"Lee J (2019b) Living with\/out dementia in contemporary South Korea. Med Anthropol Q 33(4):501\u2013516","journal-title":"Med Anthropol Q"},{"issue":"4","key":"2209_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.5124\/jkma.2009.52.4.417","volume":"52","author":"DW Lee","year":"2009","unstructured":"Lee DW, Huh YS, Kim KW (2009) Evidence-based treatment of Alzheimer\u2019s disease. Journal of the Korean Medical Association 52(4):417\u2013425","journal-title":"Journal of the Korean Medical Association"},{"issue":"5","key":"2209_CR35","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1177\/1010539512462500","volume":"24","author":"Y Lee","year":"2012","unstructured":"Lee Y, Kim S, Kim G (2012) Ethical assessment of national health insurance system of Korea. Asia Pac J Public Health 24(5):872\u2013879","journal-title":"Asia Pac J Public Health"},{"issue":"17","key":"2209_CR36","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.3390\/ijms21175953","volume":"21","author":"JH Lee","year":"2020","unstructured":"Lee JH, An HK, Sohn MG, Kivela P, Oh S (2020a) 4,4\u2032-Diaminodiphenyl sulfone (DDS) as an inflammasome competitor. Int J Mol Sci 21(17):5953","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2209_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000504880","volume":"10","author":"JH Lee","year":"2020","unstructured":"Lee JH, Choi SH, Lee CJ, Oh SS (2020b) Recovery of dementia syndrome following treatment of brain inflammation. Dement Geriatr Cogn Dis Extra 10(1):1\u201312","journal-title":"Dement Geriatr Cogn Dis Extra"},{"issue":"2","key":"2209_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000516074","volume":"11","author":"J-H Lee","year":"2021","unstructured":"Lee J-H, Lee Chul J, Park J, Lee So J, Choi S-H (2021) The neuroinflammasome in Alzheimer\u2019s disease and cerebral stroke. Dementia and Geriatric Cognitive Disorders Extra. 11(2):159\u201367","journal-title":"Dementia and Geriatric Cognitive Disorders Extra."},{"issue":"24","key":"2209_CR39","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1212\/WNL.0b013e3181aa52d3","volume":"72","author":"PH Lu","year":"2009","unstructured":"Lu PH, Edland SD, Teng E, Tingus K, Petersen RC, Cummings JL (2009) Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology 72(24):2115\u20132121","journal-title":"Neurology"},{"issue":"1","key":"2209_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/01.JGP.0000231744.69631.33","volume":"15","author":"MF Mendez","year":"2007","unstructured":"Mendez MF, Shapira JS, McMurtray A, Licht E (2007) Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia. Am J Geriatr Psychiatry 15(1):84\u201387","journal-title":"Am J Geriatr Psychiatry"},{"issue":"6","key":"2209_CR41","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/gps.5282","volume":"35","author":"T M\u00f6llers","year":"2020","unstructured":"M\u00f6llers T, Perna L, Stocker H, Ihle P, Schubert I, Sch\u00f6ttker B et al (2020) New use of psychotropic medication after hospitalization among people with dementia. Int J Geriatr Psychiatry 35(6):640\u2013649","journal-title":"Int J Geriatr Psychiatry"},{"issue":"4","key":"2209_CR42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1600-0404.2009.01263.x","volume":"121","author":"K Narasimhalu","year":"2010","unstructured":"Narasimhalu K, Effendy S, Sim CH, Lee JM, Chen I, Hia SB et al (2010) A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease. Acta Neurol Scand 121(4):217\u2013224","journal-title":"Acta Neurol Scand"},{"key":"2209_CR43","doi-asserted-by":"crossref","unstructured":"Nordgaard J, Melchior T (2021) Long-term arrhythmia detection using an implantable loop recorder in patients receiving psychotropic medication. JAMA Psychiatry","DOI":"10.1001\/jamapsychiatry.2021.2809"},{"key":"2209_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.tma.2017.06.001","volume":"1","author":"SC Park","year":"2017","unstructured":"Park SC (2017) Serendipity in search for longevity from experiences of Hansen people. Transl Med Aging 1:12\u201317","journal-title":"Transl Med Aging"},{"issue":"23","key":"2209_CR45","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1056\/NEJMoa050151","volume":"352","author":"RC Petersen","year":"2005","unstructured":"Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S et al (2005) Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352(23):2379\u20132388","journal-title":"N Engl J Med"},{"issue":"5","key":"2209_CR46","doi-asserted-by":"publisher","first-page":"379","DOI":"10.7326\/0003-4819-148-5-200803040-00009","volume":"148","author":"P Raina","year":"2008","unstructured":"Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M et al (2008) Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med 148(5):379\u2013397","journal-title":"Ann Intern Med"},{"issue":"11","key":"2209_CR47","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1371\/journal.pmed.0040338","volume":"4","author":"R Raschetti","year":"2007","unstructured":"Raschetti R, Albanese E, Vanacore N, Maggini M (2007) Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials. PLoS Med. 4(11):e338","journal-title":"PLoS Med."},{"issue":"1","key":"2209_CR48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/archneurol.2010.343","volume":"68","author":"LS Schneider","year":"2011","unstructured":"Schneider LS, Insel PS, Weiner MW (2011) Alzheimer\u2019s disease neuroimaging I Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer\u2019s disease neuroimaging initiative. Arch Neurol. 68(1):58\u201366","journal-title":"Arch Neurol."},{"issue":"12","key":"2209_CR49","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1001\/archneur.61.12.1852","volume":"61","author":"B Seltzer","year":"2004","unstructured":"Seltzer B, Zolnouni P, Nunez M, Goldman R, Kumar D, Ieni J et al (2004) Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial. Arch Neurol 61(12):1852\u20131856","journal-title":"Arch Neurol"},{"issue":"3","key":"2209_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1055\/a-1110-1010","volume":"53","author":"J Stingl","year":"2020","unstructured":"Stingl J, Just K, Schurig M, B\u00f6hme M, Steffens M, Schwab M et al (2020) Prevalence of psychotropic drugs in cases of severe adverse drug reactions leading to unplanned emergency visits in general hospitals. Pharmacopsychiatry 53(3):133","journal-title":"Pharmacopsychiatry"},{"key":"2209_CR51","unstructured":"Stone M. Mortality and antipsychotic drug use in dementia-related behavioral disorders. US Department of Health and Human Services: Food and Drug Administration, Center for Drug Evaluation and Research; 2005."},{"issue":"3","key":"2209_CR52","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1001\/jama.291.3.317","volume":"291","author":"PN Tariot","year":"2004","unstructured":"Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I et al (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 291(3):317\u2013324","journal-title":"JAMA"},{"issue":"8","key":"2209_CR53","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1073\/pnas.75.8.4016","volume":"75","author":"MC Tzeng","year":"1978","unstructured":"Tzeng MC, Cohen RS, Siekevitz P (1978) Release of neurotransmitters and depletion of synaptic vesicles in cerebral cortex slices by alpha-latrotoxin from black widow spider venom. Proc Natl Acad Sci U S A 75(8):4016\u20134020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9755","key":"2209_CR54","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(10)61855-7","volume":"376","author":"MMJ van Eijk","year":"2010","unstructured":"van Eijk MMJ, Roes KCB, Honing MLH, Kuiper MA, Karakus A, van der Jagt M et al (2010) Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial. The Lancet 376(9755):1829\u20131837","journal-title":"The Lancet"},{"issue":"22","key":"2209_CR55","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1212\/01.wnl.0000303815.69777.26","volume":"70","author":"B Winblad","year":"2008","unstructured":"Winblad B, Gauthier S, Scinto L, Feldman H, Wilcock GK, Truyen L et al (2008) Safety and efficacy of galantamine in subjects with mild cognitive impairment. Neurology 70(22):2024\u20132035","journal-title":"Neurology"},{"issue":"12","key":"2209_CR56","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.3390\/toxins7124862","volume":"7","author":"S Yan","year":"2015","unstructured":"Yan S, Wang X (2015) Recent advances in research on widow spider venoms and toxins. Toxins 7(12):5055\u20135067","journal-title":"Toxins"},{"issue":"12","key":"2209_CR57","doi-asserted-by":"publisher","first-page":"758","DOI":"10.5124\/jkma.2018.61.12.758","volume":"61","author":"H Youn","year":"2018","unstructured":"Youn H, Jeong H-G (2018) Pharmacotherapy for dementia. Journal of the Korean Medical Association 61(12):758\u2013764","journal-title":"Journal of the Korean Medical Association"}],"updated-by":[{"DOI":"10.1007\/s00210-022-02222-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000}}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02209-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-022-02209-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02209-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T06:04:55Z","timestamp":1666677895000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-022-02209-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,5]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["2209"],"URL":"https:\/\/doi.org\/10.1007\/s00210-022-02209-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-384861\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-384861\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-384861\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-384861\/v3","asserted-by":"object"}]},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,5]]},"assertion":[{"value":"25 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00210-022-02222-6","URL":"https:\/\/doi.org\/10.1007\/s00210-022-02222-6","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}